Investor Relations

Shareholders' Meeting 2025

Extraordinary General Meeting 2025 (December 17, 2025)

The Extraordinary General Meeting of Biotest AG took place on December 17, 2025, 10:30 a.m., at Biotest AG, Daimlerstraße 1 K, 63303 Dreieich, Germany.

preview

Invitation / Agenda of Extraordinary General Meeting 2025
PDF, 344 KB
[ Download ]

preview

Notes to agenda item 1 -Articles of association of Biotest GmbH & Co. KGaA (German Version)
PDF, 168 KB
[ Download ]

preview

Conversion Report (German Version)
PDF, 2.29 MB
[ Download ]

preview

GoR table (§ 125 Abs. 5 AktG) – (German Version)
PDF, 178 KB
[ Download ]

preview

Information on shareholders' rights – (German Version)
PDF, 130 KB
[ Download ]

preview

Total number of shares and voting rights at the time of calling the Annual General Meeting – (German Version)
PDF, 59 KB
[ Download ]

preview

Power of attorney for voting power (ordinary shareholders only) – (German Version)
PDF, 177 KB
[ Download ]

preview

Power of attorney for participation at Annual General Meeting (preference shareholders only) – (German Version)
PDF, 154 KB
[ Download ]

preview

Biotest AG's articles of association
PDF, 134 KB
[ Download ]

Here you will find the speech of Dr. Jörg Schüttrumpf from the extraordinary Shareholders' Meeting:

preview

Speech of Jörg Schüttrumpf – German Version
PDF, 746 KB
[ Download ]

preview

Result of the vote Annual General Meeting - German Version
PDF, 31 KB
[ Download ]

Subscribed capital:
39.571.452,00 EUR divided into
19.785.726 ordinary shares
19.785.726 preference shares

Cancellation of the extraordinary general meeting on 28 October 2025

Biotest AG has cancelled its extraordinary general meeting announced for Tuesday, 28 October 2025, at 10:30 a.m. (CET), which was announced in the Federal Gazette on 19 September 2025.

The extraordinary general meeting is expected to be reconvened in the near future.

Annual General Meeting 2025 (July 2, 2025)

The Annual General Meeting of Biotest AG took place on July 2, 2025, 10:30 a.m., at Biotest AG, Daimlerstraße 1 K, 63303 Dreieich, Germany.

preview

Invitation / Agenda of Annual General Meeting 2025
PDF, 301 KB
[ Download ]

preview

Notes on (agenda item 1) - German Version
PDF, 57 KB
[ Download ]

preview

Remuneration Report 2024 (agenda item 7)
PDF, 873 KB
[ Download ]

preview

Curriculum vitae Gernot Hebestreit (agenda item 8)
PDF, 22 KB
[ Download ]

preview

Management Board remuneration system (agenda item 9)
PDF, 274 KB
[ Download ]

preview

Supervisory Board remuneration system (agenda item 10)
PDF, 98 KB
[ Download ]

preview

GoR table (§ 125 Abs. 5 AktG) - German Version
PDF, 158 KB
[ Download ]

preview

Information on shareholders' rights - German Version
PDF, 101 KB
[ Download ]

preview

Power of attorney for voting power (ordinary shareholders only) - German Version
PDF, 138 KB
[ Download ]

preview

Power of attorney for participation at Annual General Meeting (preference shareholders only) – German Version
PDF, 124 KB
[ Download ]

preview

Total number of shares and voting rights at the time of calling the Annual General Meeting - German Version
PDF, 56 KB
[ Download ]

preview

Report of the Supervisory Board
PDF, 87 KB
[ Download ]

preview

Annual Report 2024
PDF, 2.27 MB
[ Download ]

preview

Annual financial statements 2024 Biotest AG - German Version
PDF, 3.58 MB
[ Download ]

preview

Biotest's articles of association
PDF, 736 KB
[ Download ]

preview

Dividend Announcement - German Version
PDF, 55 KB
[ Download ]

Here you will find the speech of Dr. Jörg Schüttrumpf from the Annual Shareholders' Meeting:

preview

Speech of Jörg Schüttrumpf – German Version
PDF, 5.18 MB
[ Download ]

Subscribed capital:
39.571.452,00 EUR divided into
19.785.726 ordinary shares
19.785.726 preference shares

preview

Result of the vote Annual General Meeting - German Version
PDF, 31 KB
[ Download ]